Erythromast 36 en es it fr

Erythromast 36 Brand names, Erythromast 36 Analogs

Erythromast 36 Brand Names Mixture

  • No information avaliable

Erythromast 36 Chemical_Formula


Erythromast 36 RX_link

No information avaliable

Erythromast 36 fda sheet

Erythromast 36 msds (material safety sheet)

Erythromast 36 Synthesis Reference

No information avaliable

Erythromast 36 Molecular Weight

167.205 g/mol

Erythromast 36 Melting Point

96 oC

Erythromast 36 H2O Solubility

2500 mg/L

Erythromast 36 State


Erythromast 36 LogP


Erythromast 36 Dosage Forms

No information avaliable

Erythromast 36 Indication

Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.

Erythromast 36 Pharmacology

Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.

Erythromast 36 Absorption

Rapidly absorbed following oral administration.

Erythromast 36 side effects and Toxicity

Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.

Erythromast 36 Patient Information

Erythromast 36 Organisms Affected

Humans and other mammals